Advice
Following a full submission.
Accepted for use within NHS Scotland.
Propofol MCT-LCT emulsion 1% is a new formulation of an existing product. It is as effective as alternative formulations of propofol. Pain on injection is significantly reduced in frequency and intensity compared with alternative formulations, though not totally eliminated. The major advantage of this formulation will be realised when co-administration of lignocaine is unnecessary.
This advice is based on the assumption that the product will be available through contract at a price that is competitive with available formulations of propofol.
Download detailed advice18KB (PDF)
Medicine details
- Medicine name:
- Propofol 1% Emulsion (Propofol-Lipura 1%)
- SMC ID:
- 53/03
- Indication:
- Induction and maintenance of general anaesthesia
- Pharmaceutical company
- B Braun Medical Ltd
- BNF chapter
- Anaesthesia
- Submission type
- Full
- Status
- Accepted
- Date advice published
- 12 January 2004